PharmaLectures.com

Courses › Pharma training by line of business › Week one at the pharma software and AI vendor: the company, the industry and Europe

Week one at the pharma software and AI vendor: the company, the industry and Europe

New hires answer pharma buyers and auditors correctly in week one, not month six.

  • 10 audio modulesthree lengths each
  • 1 h 40 min to 8 h 20 minbriefing to expanded
  • Workbook, transcript, certificateand a recorded quiz per module
  • Pharma software and AI vendorwho it is written for

Why this training matters

A junior developer ships a feature without an Annex 11 audit trail. The client's quality assurance team finds the gap in the vendor assessment and halts the rollout. Three weeks of rework later, the client has missed its submission to the European Medicines Agency.

What changes after this course

Your engineers and sales reps discuss Good Practice rules and European regulations with buyers and auditors, and place your software in the drug development lifecycle alone. You hold a certificate per learner and a training record per person.

Watch the pitch

3:43 on how an audio course is bought, listened to and recorded. Full screen, one click.

Watch the pitch3:43, full screen, one click

What this course gives your people

Your sales rep stops freezing when a prospect asks about European Medicines Agency submission formats. She places your tool in the drug development lifecycle, from preclinical research to post-market surveillance, and names the step it speeds up without promising anything Good Clinical Practice would not allow. The prospect hears someone who knows the work.

Engineers ship code that passes the vendor audit the first time. They apply Annex 11 to electronic signatures and backups, and they build audit trails that satisfy the Attributable, Legible, Contemporaneous, Original and Accurate principles. Project managers answer a quality assurance question on the spot instead of promising to come back next week.

Proposals say plainly whether Medical Devices Regulation 2017/745 applies to your artificial intelligence feature, and how the General Data Protection Regulation is met. Account managers talk about EudraVigilance integration without mixing up an adverse event and an adverse drug reaction, which tells pharmacovigilance teams that people who know the rules built your safety reporting tool.

Managers stop hand-holding. A new hire opens a client email about Clinical Trials Regulation 536/2014 hosting or Good Manufacturing Practice user permissions and drafts a correct reply, because the module already covered it. Each learner finishes with a recorded questionnaire result per module.

Who needs this training

  • Sales Manager, Pharma Software

    A prospect asks how your artificial intelligence tool meets the General Data Protection Regulation, and your rep answers clearly in the meeting instead of promising a call back.

  • Lead Software Engineer

    Your team designs a new module this sprint and needs to know how to structure the audit trail so it passes an Annex 11 check.

  • Implementation Project Manager

    A European client wants proof that your system keeps Attributable, Legible, Contemporaneous, Original and Accurate records before signing off testing on Monday.

  • Account Executive

    They pitch a new safety reporting dashboard and explain how it connects to EudraVigilance, without confusing adverse events with adverse drug reactions.

Roles: every role in the company

Businesses: Pharma software and AI vendor

Countries: India, China, Türkiye, Korea, Japan, Taiwan, Egypt, Gulf and MENA, Brazil and Latin America, Pakistan, Bangladesh and Vietnam, United States, Europe

Selling into: Europe and the UK

Courses are in English. Other languages on request.

After this course your people can

  1. Name the European Medicines Agency requirements your software fulfils, with the document that backs each one.
  2. Specify an Annex 11 audit trail for a new release before the sprint starts.
  3. Show a client auditor how your system keeps records attributable, legible, contemporaneous, original and accurate.
  4. Place each artificial intelligence feature at the drug development stage where it removes a bottleneck.
  5. Say whether Medical Devices Regulation 2017/745 applies to your product, and give the reason.
  6. Explain EudraVigilance integration to a pharmacovigilance team without mixing up adverse events and adverse drug reactions.

What the company gets

  • Your sales team closes deals faster because buyers hear the regulatory language they expect from the first call.
  • Releases hold their dates because engineers stop writing code that quality assurance sends back late in the cycle.
  • Client vendor assessments go smoothly, because training records show who on your team has covered Annex 11 and data integrity.
  • New hires reach useful pharmaceutical knowledge in their first week, so senior staff spend less time answering basic questions.

The evidence: questionnaire, training record, certificate

EU GMP Chapter 2, section 2.11, and 21 CFR 211.25 both ask for training that is documented and shown to work. This is what each learner leaves behind.

A recorded questionnaire per module

Every one of the 10 modules ends with a multiple-choice questionnaire. The result is recorded per person with a timestamp, whichever of the three lengths the person listened to.

A per-person training record

The export lists each learner, each module, the result and the date, which is the training record EU GMP Chapter 2 and 21 CFR 211.25 ask you to keep and the first thing an inspector asks for.

A certificate per learner

Name, company, course, hours, the guideline version taught and the date. It documents in-company training; it is not a professional qualification or an accreditation.

Your pass mark, your rule

There is no fixed pass mark. Your quality or human-resources manager decides what counts as passed and when a module is retaken, exactly as your training procedure says.

Delivered within 72 hours of payment, with the workbook, the full transcript and a source for every fact in the audio.

How long it takes, by who is listening

Nobody spends a day in a classroom. Every module exists in three lengths; a person takes the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Briefing1 h 40 min10 min a module, for executives, sales and anyone who must know the rules, not run them
Standard4 h 10 min25 min a module, for regulatory, quality and business-development staff
Expanded8 h 20 min50 min a module, for technical staff who run the procedure day to day
Who takes this courseLengthTotal time
Owner, CEO and boardBriefing1 h 40 min
Business development and export salesBriefing1 h 40 min
Finance, pricing and tendersBriefing1 h 40 min
Marketing and communicationsBriefing1 h 40 min
Human resources and onboardingBriefing1 h 40 min
IT, data and validationBriefing1 h 40 min
Regulatory affairsStandard4 h 10 min
Quality assurance and Qualified PersonStandard4 h 10 min
Quality control and laboratoryStandard4 h 10 min
Production and engineeringStandard4 h 10 min
Supply chain, purchasing and logisticsStandard4 h 10 min
Pharmacovigilance and medicalStandard4 h 10 min

Course outline: 10 modules

10 modules. Under each title are the three things the listener can do afterwards; the audio itself runs 10 to 50 minutes depending on the length chosen.

  1. 1Map the pharmaceutical landscape to spot who buys your software

    • How to read a prospect's pipeline and see which of your features saves their scientists hours.
    • Why a buyer in one region needs a different first demo than a buyer in another.
    • What a sponsor's business model tells you about the pilot you should offer first.
  2. 2Match your software features to European Medicines Agency demands

    • How to show that software-generated trial data meets European Medicines Agency expectations.
    • What a national competent authority inspector checks on a system running in their country.
    • What the Committee for Medicinal Products for Human Use weighs in submitted data, and where you help.
  3. 3Build Good Practice compliance into your development sprints

    • Why Good Clinical Practice decides how you build audit trails in trial management software.
    • How Good Manufacturing Practice turns into the user permissions in your production system.
    • The Good Pharmacovigilance Practice rules that decide how your tool records and submits safety cases.
  4. 4Align your product roadmap with European Union rules and Annex 11

    • What Clinical Trials Regulation 536/2014 means for how you keep, archive and protect trial data.
    • When your software counts as a device under Medical Devices Regulation 2017/745, and when not.
    • The Annex 11 rules on electronic signatures and backups that your next release must meet.
  5. 5Pinpoint where your software fits in the drug development lifecycle

    • How to follow a compound from preclinical research to post-market surveillance without getting lost.
    • The exact points in the lifecycle where your software removes manual data entry.
    • Why data handoffs between stages break, and how your system stops the drop.
  6. 6Prove data integrity with Attributable and Legible records in audits

    • How to apply Attributable, Legible, Contemporaneous, Original and Accurate to your own system's records.
    • What happens in a client vendor assessment when one record fails the data integrity test.
    • What European Medicines Agency guidance expects you to do to keep raw data safe from alteration.
  7. 7Support pharmacovigilance teams with compliant safety reporting tools

    • Why adverse event systems need accurate timestamps to pass an inspection.
    • The difference between an adverse event and an adverse drug reaction in your database.
    • How reporting deadlines for suspected unexpected serious adverse reactions shape your system alerts.
  8. 8Catch pharma software project mistakes before they delay release

    • Why bringing quality assurance in late makes you rewrite code that worked.
    • The delays that hit when you validate to Good Practice standards too late.
    • What to do when regulatory change threatens your release date.
  9. 9Speak the exact language of your pharmaceutical software buyers

    • How to swap generic tech jargon for the terms clinical researchers use daily.
    • The compliance and data security points your client needs to hear in the first meeting.
    • What to say when a prospect asks how your tool keeps them ready for an audit.
  10. 10Pitch your artificial intelligence solutions to skeptical pharma buyers

    • How to describe your artificial intelligence models without setting off compliance alarms.
    • The ethical and regulatory hurdles to clear before you deploy artificial intelligence in a pharma client.
    • Why tying each feature to a named drug discovery bottleneck closes deals faster.
The founders

One of us was inspected. The other one pays for the training.

Every claim below is sourced on the about page: the medicines register, the Lithuanian Pharmaceutical Union board list, the university directory.

Justina Krukonytė-Racz

Justina Krukonytė-Racz

Co-founder. Licensed pharmacist.

GDPResponsible PersonWarehouse & logistics

Licensed pharmacist. Responsible Person at Tamro (PHOENIX group), where she led the GDP set-up of the distribution centre.

The Responsible Person is the named person the regulator holds accountable for every pallet that leaves the building.

She writes the modules around the procedures a GDP inspection checks. Board member of Lithuanian Pharmaceutical Union.

Listed in the Lithuanian medicines register as Pharmacist.

Prof. Ben Racz

Prof. Ben Racz

Co-founder. Builds the platform and is responsible for delivery, records and pricing.

Platform & deliveryQuantitative researchCarnegie Mellon

He was Professor of the Practice at the College of Engineering at Carnegie Mellon University, where he taught Advanced Quantitative Finance and Algorithmic Trading to MSc students.

He is the founder and Managing Director of Algorithmic Sciences, a scientific research and consulting firm. Earlier he co-founded a data-driven growth consultancy, a data-science based wholesale trading company and an information security firm.

More about Ben at benracz.com

Questions about this course

Is there a certificate?

Yes. Every learner who finishes the course receives a certificate in their own name, and every module ends with a recorded multiple-choice questionnaire, so the certificate sits on top of a per-person training record. The certificate documents in-company training; it is not a professional qualification or an accreditation, and your quality or human-resources manager sets the pass mark and decides when a module is retaken.

How long does the course take?

10 modules, each in three lengths: a 10-minute briefing, a 25-minute standard run and a 50-minute expanded walk-through. The whole course takes 1 h 40 min in the briefing length and 8 h 20 min in the expanded length. People take the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Who should take this course?

It is written for Pharma software and AI vendor. Owners, managers and sales staff hear the briefing length, regulatory, quality and business-development staff take the standard run, and the people who run the procedure every day get the expanded version. One licence covers one named person on this course for a year, so the same title can be rolled out across a whole team at once.

Is this training accepted as a GMP training record by an auditor?

EU GMP Chapter 2 and 21 CFR 211.25 require documented, effective training, and that is what the course produces: a recorded multiple-choice result per module and per person, a certificate per learner and a transcript of what was taught. No provider can promise acceptance by a specific inspector; the record is built to answer what inspectors ask for, and your quality manager decides the pass mark.

How is it delivered and how fast?

The course arrives as audio files with a companion workbook, a full transcript and the questionnaire per module, within 72 hours of your payment arriving. You host the files on your own system or share them as you like; there is no platform to log into and no learner management system to set up. The free sample module arrives on request, before any purchase.

What does it cost per learner?

The list price is 9 euros per module, per learner, per year, so this course is 90 euros for one person for twelve months. The price per learner falls as more people take the same course: 10 learners pay 10 percent less and the discount keeps growing to 50 percent at 1000 learners. Type a number on the price panel and the yearly total appears.

Get this course for your team

One licence is one person on this course for a year. All three lengths, the workbook, the certificate and the training record are included in every purchase. Pick how many people, add it to the cart, and you have an invoice in your inbox.

Free sample module

Hear one full module before you spend a cent. Send your company and the role you want trained, and a complete sample module comes back with its workbook and transcript.

Connect on WhatsApp

or email [email protected], or ask for a written quote for your team